Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)
He has been associated with the Zydus Group since 2009
He has been associated with the Zydus Group since 2009
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Baruah will lead strategy, growth, and transformation across the HLS vertical, focusing on expanding digital health capabilities and accelerating AI adoption
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Subscribe To Our Newsletter & Stay Updated